Mumbai: In the wake of 20 children’s deaths in Madhya Pradesh due to contaminated cough syrup, Maharashtra’s Food and Drug Administration (FDA) has swung into action — ordering 88 drug retailers across the state to immediately stop selling medicines.
The FDA has also issued show-cause notices to 107 other chemists for allegedly selling cough syrups and other drugs without valid prescriptions, warning that their licenses could be suspended or revoked.
Statewide Inspections Launched To Prevent Contaminated Drugs
The move comes as part of a larger state-wide inspection drive to ensure that substandard or contaminated liquid medicines do not reach patients. Following the Madhya Pradesh tragedy, FDA Commissioner Rajesh Narvekar convened a high-level meeting directing all Joint Commissioners and Drug Inspectors to conduct intensive inspections across government, municipal, and private hospitals, as well as retail and wholesale distributors.
Samples Collected and Sent for Testing
Inspectors have been instructed to collect samples of liquid oral formulations (drugs administered orally in liquid form) and send them to laboratories for testing. They are also required to immediately report the details of all manufacturers producing liquid medicines and seize any suspicious or contaminated stock found at hospitals, distributors, or production facilities.
Also Watch:
Testing to Be Conducted in Mumbai and Chhatrapati Sambhajinagar Labs
Confirming the action, FDA Drug Controller D.R. Gahane said that samples from the Mumbai, Konkan, Pune, and Nashik divisions will be sent to a Mumbai-based lab, while those from Chhatrapati Sambhajinagar, Amravati, and Nagpur will be tested in the Chhatrapati Sambhajinagar laboratory.
To get details on exclusive and budget-friendly property deals in Mumbai & surrounding regions, do visit: https://budgetproperties.in/
